 |
|
Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel
Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, Sun Il Kim
J Urol Oncol. 2023;21(3):271-276. Published online 2023 Nov 30 DOI: https://doi.org/10.22465/juo.234600440022
|
|
Citations to this article as recorded by
 Summarizing the Intentions and Outcomes of JUO 2023 Issue 3
Cheol Kwak
Journal of Urologic Oncology.2023; 21(3): 181. CrossRef
|